Matetzky, Shlomi <br/><br/>
Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction.  [electronic resource] 

 -  Circulation  Jun 2004 
 - 3171-5 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1524-4539 
<br/><br/><label>Standard No.: </label>10.1161/01.CIR.0000130846.46168.03  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenosine Diphosphate--antagonists & inhibitors<br/>Aged<br/>Aspirin--administration & dosage<br/>Biotransformation<br/>Clopidogrel<br/>Combined Modality Therapy<br/>Coronary Artery Disease--complications<br/>Coronary Restenosis--epidemiology<br/>Coronary Thrombosis--epidemiology<br/>Drug Resistance<br/>Drug Therapy, Combination<br/>Epinephrine--administration & dosage<br/>Eptifibatide<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Male<br/>Middle Aged<br/>Myocardial Infarction--drug therapy<br/>Peptides--therapeutic use<br/>Platelet Aggregation--drug effects<br/>Platelet Aggregation Inhibitors--pharmacology<br/>Prodrugs--pharmacology<br/>Prospective Studies<br/>Purinergic P2 Receptor Antagonists<br/>Recurrence<br/>Risk<br/>Smoking--epidemiology<br/>Stents<br/>Ticlopidine--analogs & derivatives<br/>Treatment Outcome